Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Mingyang Wang, Xiaosheng Fang & Xin Wang. (2020) Emerging role of histone deacetylase inhibitors in the treatment of diffuse large B-cell lymphoma. Leukemia & Lymphoma 61:4, pages 763-775.
Read now
Read now
Tony Reiman, Kerry J. Savage, Michael Crump, Matthew C. Cheung, David MacDonald, Rena Buckstein, Stephen Couban, Eugenia Piliotis, Kevin Imrie, David Spaner, Sudeep Shivakumar, John Kuruvilla, Diego Villa, Lois E. Shepherd, Tanya Skamene, Chad Winch, Bingshu E. Chen & Annette E. Hay. (2019) A phase I study of romidepsin, gemcitabine, dexamethasone and cisplatin combination therapy in the treatment of peripheral T-cell and diffuse large B-cell lymphoma; the Canadian cancer trials group LY.15 study†. Leukemia & Lymphoma 60:4, pages 912-919.
Read now
Read now
Aaron P. Havas, Kameron B. Rodrigues, Anvi Bhakta, Joseph A. Demirjian, Seongmin Hahn, Jack Tran, Margarethakay Scavello, Ana A. Tula-Sanchez, Yi Zeng, Monika Schmelz & Catharine L. Smith. (2016) Belinostat and vincristine demonstrate mutually synergistic cytotoxicity associated with mitotic arrest and inhibition of polyploidy in a preclinical model of aggressive diffuse large B cell lymphoma. Cancer Biology & Therapy 17:12, pages 1240-1252.
Read now
Read now
Concepción Fernández-Rodríguez, Antonio Salar, Alfons Navarro, Eva Gimeno, Silvia Pairet, Laura Camacho, Mariana Ferraro, Sergi Serrano, Carles Besses, Beatriz Bellosillo & Blanca Sanchez-Gonzalez. (2016) Anti-tumor activity of the combination of bendamustine with vorinostat in diffuse large B-cell lymphoma cells. Leukemia & Lymphoma 57:3, pages 692-699.
Read now
Read now
Articles from other publishers (13)
Aaron P. Havas, Ana A. Tula-Sanchez, Hailey M. Steenhoek, Anvi Bhakta, Taylor Wingfield, Matthew J. Huntley, Angela S. Nofal, Tasmia Ahmed, Rosa Jaime-Frias & Catharine L. Smith. (2024) Defining cellular responses to HDAC-selective inhibitors reveals that efficient targeting of HDAC3 is required to elicit cytotoxicity and overcome naïve resistance to pan-HDACi in diffuse large B cell lymphoma. Translational Oncology 39, pages 101779.
Crossref
Crossref
Tobias Kiesslich, Christian Mayr, Dino Bekric & Daniel Neureiter. (2023) New insights into possible HDAC inhibitor resistance in DLBCL - Comment on 'defining cellular responses to HDAC-selective inhibitors reveals that efficient targeting of HDAC3 is required to elicit cytotoxicity and overcome naïve resistance to pan-HDACi in diffuse large B cell lymphoma' by Havas et al.. Translational Oncology, pages 101820.
Crossref
Crossref
Qinglang Mei, Xiaohan Xu, Danling Gao, Yuting Xu & Jinbo Yang. (2023) Inhibition of Notch Signaling Enhances Antitumor Activity of Histone Deacetylase Inhibitor LAQ824. International Journal of Molecular Sciences 24:17, pages 13660.
Crossref
Crossref
Luqiao Wang, Zijuan Wu, Yi Xia, Xueying Lu, Ji Li, Lei Fan, Chun Qiao, Hairong Qiu, Danling Gu, Wei Xu, Jianyong Li & Hui Jin. (2022) Single‐cell profiling‐guided combination therapy of c‐Fos and histone deacetylase inhibitors in diffuse large B‐cell lymphoma. Clinical and Translational Medicine 12:5.
Crossref
Crossref
Michael Y. He & Robert Kridel. (2021) Treatment resistance in diffuse large B-cell lymphoma. Leukemia 35:8, pages 2151-2165.
Crossref
Crossref
Godefridus J. Peters, Frank P. A. van Gemert, Ietje Kathmann, Guru Reddy, Saskia A. G. M. Cillessen & Gerrit Jansen. (2020) Schedule-Dependent Synergy Between the Histone Deacetylase Inhibitor Belinostat and the Dihydrofolate Reductase Inhibitor Pralatrexate in T-and B-cell Lymphoma Cells in vitro. Frontiers in Cell and Developmental Biology 8.
Crossref
Crossref
ommolbanin younesian, samareh younesian, sara hosseinzadeh & hamid reza joshaghani. (2020) Association of Selenium and Risk of Esophageal Cancer: A Review. Medical Laboratory Journal 14:1, pages 1-9.
Crossref
Crossref
Zhen Zhou, Qin Fang, Dan Ma, Nana Zhe, Mei Ren, Bingqing Cheng, Peifan Li, Ping Liu, Xiaojing Lin, Sishi Tang, Xiuying Hu, Yudan Liao, Yaming Zhang, Tingting Lu & Jishi Wang. (2017)
Silencing heme oxygenase-1 increases the sensitivity of ABC-DLBCL cells to histone deacetylase inhibitor
in vitro
and
in vivo
. Oncotarget 8:45, pages 78480-78495.
Crossref
Crossref
Peter Campbell & Christan M Thomas. (2016) Belinostat for the treatment of relapsed or refractory peripheral T-cell lymphoma. Journal of Oncology Pharmacy Practice 23:2, pages 143-147.
Crossref
Crossref
Kun Wang, Xiao-ting Fu, Yuan Li, Ya-jun Hou, Ming-feng Yang, Jing-yi Sun, Shu-ying Yi, Cun-dong Fan, Xiao-yan Fu, Jing Zhai & Bao-liang Sun. (2016) Induction of S-Phase Arrest in Human Glioma Cells by Selenocysteine, a Natural Selenium-Containing Agent Via Triggering Reactive Oxygen Species-Mediated DNA Damage and Modulating MAPKs and AKT Pathways. Neurochemical Research 41:6, pages 1439-1447.
Crossref
Crossref
Michaela Angelika Ihle, Sabine Merkelbach‐Bruse, Wolfgang Hartmann, Sebastian Bauer, Nancy Ratner, Hiroshi Sonobe, Jun Nishio, Olle Larsson, Pierre Åman, Florence Pedeutour, Takahiro Taguchi, Eva Wardelmann, Reinhard Buettner & Hans‐Ulrich Schildhaus. (2016) HR23b expression is a potential predictive biomarker for HDAC inhibitor treatment in mesenchymal tumours and is associated with response to vorinostat. The Journal of Pathology: Clinical Research 2:2, pages 59-71.
Crossref
Crossref
JUNFEN MA, XIAOBING GUO, SHIJIE ZHANG, HONGCHUN LIU, JING LU, ZIMING DONG, KANGDONG LIU & LIANG MING. (2015) Trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and promotes apoptosis of esophageal squamous cell lines. Molecular Medicine Reports 11:6, pages 4525-4531.
Crossref
Crossref
Afua Adjeiwaa Mensah, Ivo Kwee, Eugenio Gaudio, Andrea Rinaldi, Maurilio Ponzoni, Luciano Cascione, Gianluca Fossati, Anastasios Stathis, Emanuele Zucca, Gianluca Caprini & Francesco Bertoni. (2014)
Novel HDAC inhibitors exhibit pre-clinical efficacy in lymphoma models and point to the importance of
CDKN1A
expression levels in mediating their anti-tumor response
. Oncotarget 6:7, pages 5059-5071.
Crossref
Crossref